Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 4:49 PM
Ignite Modification Date: 2025-12-25 @ 2:34 PM
NCT ID: NCT00840450
Description: None
Frequency Threshold: 5
Time Frame: treatment period (up to 5 months) plus 30 days after treatment or until the the adverse events have resolved or returned to pretreatment values or deemed irreversible.
Study: NCT00840450
Study Brief: Imatinib Mesylate (Gleevec) and Paclitaxel in Recurrent Patients of Ovarian and Other Cancers of Mullerian Origin
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Paclitaxel and Imatinib Mesylate (Gleevec) None None None 3 12 11 12 View
Serious Events(If Any):

Serious Events

Term Type Organ System Vocab View
Neutropenia SYSTEMATIC_ASSESSMENT Blood and lymphatic system disorders CTCAE (Unspecified) View
Diarrhea SYSTEMATIC_ASSESSMENT Gastrointestinal disorders CTCAE (Unspecified) View
Thrombocytopenia SYSTEMATIC_ASSESSMENT Blood and lymphatic system disorders CTCAE (Unspecified) View
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Alopecia SYSTEMATIC_ASSESSMENT General disorders CTCAE (Unspecified) View
Anemia SYSTEMATIC_ASSESSMENT Blood and lymphatic system disorders CTCAE (Unspecified) View
Edema SYSTEMATIC_ASSESSMENT General disorders CTCAE (Unspecified) View
Headache SYSTEMATIC_ASSESSMENT General disorders CTCAE (Unspecified) View
Myalgia SYSTEMATIC_ASSESSMENT Musculoskeletal and connective tissue disorders CTCAE (Unspecified) View
Neuropathy SYSTEMATIC_ASSESSMENT Nervous system disorders CTCAE (Unspecified) View
Palpitation SYSTEMATIC_ASSESSMENT Cardiac disorders CTCAE (Unspecified) View
Shortness of breath SYSTEMATIC_ASSESSMENT Cardiac disorders CTCAE (Unspecified) View
Thrombocytopenia SYSTEMATIC_ASSESSMENT Blood and lymphatic system disorders CTCAE (Unspecified) View
skin toxicity SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders CTCAE (Unspecified) View
Diarrhea SYSTEMATIC_ASSESSMENT Gastrointestinal disorders CTCAE (Unspecified) View
Fatigue SYSTEMATIC_ASSESSMENT General disorders CTCAE (Unspecified) View
Mucostitis SYSTEMATIC_ASSESSMENT Gastrointestinal disorders CTCAE (Unspecified) View
Nausea SYSTEMATIC_ASSESSMENT Gastrointestinal disorders CTCAE (Unspecified) View
Neutropenia SYSTEMATIC_ASSESSMENT Blood and lymphatic system disorders CTCAE (Unspecified) View
Vomiting SYSTEMATIC_ASSESSMENT Gastrointestinal disorders CTCAE (Unspecified) View